Zydus Lifesciences (BOM:532321) Days Sales Outstanding : 82.25 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences Days Sales Outstanding?

Zydus Lifesciences's average Accounts Receivable for the three months ended in Dec. 2023 was ₹39,152 Mil. Zydus Lifesciences's Revenue for the three months ended in Dec. 2023 was ₹43,437 Mil. Hence, Zydus Lifesciences's Days Sales Outstanding for the three months ended in Dec. 2023 was 82.25.

The historical rank and industry rank for Zydus Lifesciences's Days Sales Outstanding or its related term are showing as below:

BOM:532321' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.77 Med: 82 Max: 102.46
Current: 79.26

During the past 13 years, Zydus Lifesciences's highest Days Sales Outstanding was 102.46. The lowest was 52.77. And the median was 82.00.

BOM:532321's Days Sales Outstanding is ranked worse than
57.76% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.38 vs BOM:532321: 79.26

Zydus Lifesciences's Days Sales Outstanding increased from Dec. 2022 (81.71) to Dec. 2023 (82.25).

Zydus Lifesciences Days Sales Outstanding Historical Data

The historical data trend for Zydus Lifesciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences Days Sales Outstanding Chart

Zydus Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

102.46

100.60

87.74

79.60

83.88

Zydus Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															81.71	83.06	79.76	83.89	82.25

Competitive Comparison of Zydus Lifesciences's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Zydus Lifesciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zydus Lifesciences's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zydus Lifesciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zydus Lifesciences's Days Sales Outstanding falls into.

Zydus Lifesciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zydus Lifesciences's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (33403	+	44168)	/	2 )	/	168778	*	365
=	38785.5					/	168778	*	365
=	83.88

Zydus Lifesciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (39152	+	0)	/	1 )	/	43437	*	365 / 4
=	39152					/	43437	*	365 / 4
=	82.25

Zydus Lifesciences (BOM:532321) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Zydus Lifesciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Zydus Lifesciences (BOM:532321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

ZYDUSLIFE:India

Address

Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481

Website

https://www.zyduslife.com

Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines